It’s been reported that there is a drug that is advertised as having a successful impact on people who suffer from covid and cancer. Check out the latest reports below.
New drug successful against covid and cancer?
While vaccination can provide life-saving protection against covid-19, scientists are still searching for ways to treat severe infections, including in people who cannot get vaccinated or in the event that dangerous new strains of the virus arise that could bypass vaccine protection.
According to the latest reports, there is a new study from a team of researchers led by Amy S. Lee, Ph.D., professor of biochemistry and molecular medicine at the Keck School of Medicine of USC, which shows that a chaperone protein known as GRP78, implicated in the spread of other viruses, plays an essential role in the spread of SARS-CoV-2, the virus that causes covid.
The study also shows that blocking the production of GRP78, or inhibiting its activity with a new targeted drug, greatly reduced the replication of SARS-CoV-2.
The research has just been published in the journal Nature Communications, and it suggests this drug could potentially offer a new type of protection against covid, one that might remain effective even as new strains develop.
“A major problem in fighting SARS-CoV-2 is that it is constantly mutating and adapting itself to more efficiently infect and multiply in its host cells,” said Lee, also the Judy and Larry Freeman Chair in basic science research.
The same expert said the following:
“If we keep chasing the virus around, this could become quite challenging and unpredictable.”
In other recent news, it’s been just revealed that the drugmaker AstraZeneca said on Friday its lung cancer drugs Imfinzi and Imjudo have been approved by the U.S. Food and Drug Administration (FDA) when used along with chemotherapy for the treatment of adults with stage IV non-small cell lung cancer.